In Vivo Evaluation Using Gamma Scintigraphy - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

In Vivo Evaluation Using Gamma Scintigraphy
The authors discuss gamma scintigraphy as a technique for in vivo evaluation of drugs and delivery systems.

Pharmaceutical Technology

Radiolabeling techniques

Several approaches for radiolabeling are available. Whole-dose radiolabeling, point radiolabeling, surrogate markers, and neutron activation are predominantly used (6, 9–12).

Whole-dose radiolabeling . Whole-dose radiolabeling uniformly incorporates radiolabeled-carrier particles within the formulation matrix during manufacture. This approach is particularly important when the key objective is to assess the release pattern of a drug from the dosage form over time.

Point radiolabeling . Point radiolabeling also is known as drill and fill, by which the radiolabeled-carrier particles are inserted into a hole drilled within the surface of a tablet, which is subsequently sealed. The radiolabel acts as a marker for location in the GI tract and also provides some information about the physical integrity of the dosage forms.

Surrogate markers . Surrogate markers generally are useful for several multiparticulate systems. In these studies, a second population (e.g., ion-exchange resin or nonpareil beads), labeled with a suitable radionuclide, is mixed with drug pellets. These radiolabeled pellets reveal the information on the location of the drug containing pellets in the GI tract, and data can be further correlated with a pharmacokinetic profile.

Neutron activation . Under neutron activation, a stable isotope is incorporated into the dosage form before its manufacture, which is followed by neutron irradiation of the intact dosage form. Thermal neutron irradiation converts the carefully selected stable isotopes (i.e., 152Sm or 170Er) into radioactive gamma-emitting isotopes (i.e., 153Sm or 171Er) that can be detected by external imaging devices.

Scintillation camera

Gamma camera, also called scintillation camera or Anger camera, is a device used to detect and image gamma radiation emitted from a radionuclide. A gamma camera is provided with a scintillator that exhibits the property of luminescence and transforms the gamma radiation into an emission of light. Monocrystals of sodium iodide, activated by thallium, is the most commonly used scintillator. A collimator made of lead is placed immediately in front of the crystal to stop and filter a stream of radiation arriving at an angle. A photomultiplier array and electronic circuitry are used for amplifying the light signal produced in the crystal, quantifying the intensity of the incident gamma rays, and locating its origin. It is thus possible to determine the distribution of the tracer on an image formed as a matrix of pixels (8). This image is subsequently computer-processed to accurately determine the distribution and relative concentration of a radioactive tracer element in the organs and tissues imaged, or in the so-called regions of interest.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here